Reduction of infection-stimulated periapical bone resorption by the biological response modifier PGG glucan.

P. Stashenko, C. Y. Wang, E. Riley, Y. Wu, Richard Niederman, R. Niederman

Research output: Contribution to journalArticle

Abstract

Pulpal and periodontal diseases are bacterial infections which result in local connective tissue and bone destruction. Effective host resistance to these infections is primarily mediated by neutrophils and other phagocytic cells. PGG glucan (poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan) is a biological response modifier which stimulates the production of neutrophils and upregulates their phagocytic and bactericidal activity. In the present studies, the effect of PGG glucan on infection-stimulated alveolar bone resorption was tested in an in vivo model. Periapical bone resorption was induced in Sprague-Dawley rats by surgical pulp exposure and subsequent infection from the oral environment. Animals were administered PGG glucan (0.5 mg/kg) or saline (control) subcutaneously the day before and on days 2, 4, 6, 9, 11, 13, 16, and 18 following the pulp exposure procedure. PGG glucan enhanced the number of circulating neutrophils and monocytes and increased neutrophil phagocytic activity approximately two-fold. PGG glucan-treated animals had significantly less infection-stimulated periapical bone resorption than control animals, as determined radiographically (-48.0%; p < 0.001) and by histomorphometry (-40.8% and -42.4% for first and second molars, respectively; p < 0.001). PGG glucan-treated animals also had less soft tissue destruction, as indicated by decreased pulpal necrosis. Only 3.3% of the first molar pulps from PGG glucan-treated animals exhibited complete necrosis, as compared with 40.6% of pulps from controls. Finally, PGG glucan had no effect on either PTH- or IL-1-stimulated bone resorption in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)

Original languageEnglish (US)
Pages (from-to)323-330
Number of pages8
JournalJournal of Dental Research
Volume74
Issue number1
StatePublished - Jan 1995

Fingerprint

Immunologic Factors
Bone Resorption
Infection
Neutrophils
Necrosis
Alveolar Bone Loss
Glucans
poly-1-6-glucopyranosyl-1-3-glucopyranose glucan
Periodontal Diseases
Phagocytes
Interleukin-1
Bacterial Infections
Connective Tissue
Sprague Dawley Rats
Monocytes
Up-Regulation
Bone and Bones

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Reduction of infection-stimulated periapical bone resorption by the biological response modifier PGG glucan. / Stashenko, P.; Wang, C. Y.; Riley, E.; Wu, Y.; Niederman, Richard; Niederman, R.

In: Journal of Dental Research, Vol. 74, No. 1, 01.1995, p. 323-330.

Research output: Contribution to journalArticle

Stashenko, P. ; Wang, C. Y. ; Riley, E. ; Wu, Y. ; Niederman, Richard ; Niederman, R. / Reduction of infection-stimulated periapical bone resorption by the biological response modifier PGG glucan. In: Journal of Dental Research. 1995 ; Vol. 74, No. 1. pp. 323-330.
@article{a2e0e0d435ab44e296531f6303395901,
title = "Reduction of infection-stimulated periapical bone resorption by the biological response modifier PGG glucan.",
abstract = "Pulpal and periodontal diseases are bacterial infections which result in local connective tissue and bone destruction. Effective host resistance to these infections is primarily mediated by neutrophils and other phagocytic cells. PGG glucan (poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan) is a biological response modifier which stimulates the production of neutrophils and upregulates their phagocytic and bactericidal activity. In the present studies, the effect of PGG glucan on infection-stimulated alveolar bone resorption was tested in an in vivo model. Periapical bone resorption was induced in Sprague-Dawley rats by surgical pulp exposure and subsequent infection from the oral environment. Animals were administered PGG glucan (0.5 mg/kg) or saline (control) subcutaneously the day before and on days 2, 4, 6, 9, 11, 13, 16, and 18 following the pulp exposure procedure. PGG glucan enhanced the number of circulating neutrophils and monocytes and increased neutrophil phagocytic activity approximately two-fold. PGG glucan-treated animals had significantly less infection-stimulated periapical bone resorption than control animals, as determined radiographically (-48.0{\%}; p < 0.001) and by histomorphometry (-40.8{\%} and -42.4{\%} for first and second molars, respectively; p < 0.001). PGG glucan-treated animals also had less soft tissue destruction, as indicated by decreased pulpal necrosis. Only 3.3{\%} of the first molar pulps from PGG glucan-treated animals exhibited complete necrosis, as compared with 40.6{\%} of pulps from controls. Finally, PGG glucan had no effect on either PTH- or IL-1-stimulated bone resorption in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)",
author = "P. Stashenko and Wang, {C. Y.} and E. Riley and Y. Wu and Richard Niederman and R. Niederman",
year = "1995",
month = "1",
language = "English (US)",
volume = "74",
pages = "323--330",
journal = "Journal of Dental Research",
issn = "0022-0345",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Reduction of infection-stimulated periapical bone resorption by the biological response modifier PGG glucan.

AU - Stashenko, P.

AU - Wang, C. Y.

AU - Riley, E.

AU - Wu, Y.

AU - Niederman, Richard

AU - Niederman, R.

PY - 1995/1

Y1 - 1995/1

N2 - Pulpal and periodontal diseases are bacterial infections which result in local connective tissue and bone destruction. Effective host resistance to these infections is primarily mediated by neutrophils and other phagocytic cells. PGG glucan (poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan) is a biological response modifier which stimulates the production of neutrophils and upregulates their phagocytic and bactericidal activity. In the present studies, the effect of PGG glucan on infection-stimulated alveolar bone resorption was tested in an in vivo model. Periapical bone resorption was induced in Sprague-Dawley rats by surgical pulp exposure and subsequent infection from the oral environment. Animals were administered PGG glucan (0.5 mg/kg) or saline (control) subcutaneously the day before and on days 2, 4, 6, 9, 11, 13, 16, and 18 following the pulp exposure procedure. PGG glucan enhanced the number of circulating neutrophils and monocytes and increased neutrophil phagocytic activity approximately two-fold. PGG glucan-treated animals had significantly less infection-stimulated periapical bone resorption than control animals, as determined radiographically (-48.0%; p < 0.001) and by histomorphometry (-40.8% and -42.4% for first and second molars, respectively; p < 0.001). PGG glucan-treated animals also had less soft tissue destruction, as indicated by decreased pulpal necrosis. Only 3.3% of the first molar pulps from PGG glucan-treated animals exhibited complete necrosis, as compared with 40.6% of pulps from controls. Finally, PGG glucan had no effect on either PTH- or IL-1-stimulated bone resorption in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)

AB - Pulpal and periodontal diseases are bacterial infections which result in local connective tissue and bone destruction. Effective host resistance to these infections is primarily mediated by neutrophils and other phagocytic cells. PGG glucan (poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan) is a biological response modifier which stimulates the production of neutrophils and upregulates their phagocytic and bactericidal activity. In the present studies, the effect of PGG glucan on infection-stimulated alveolar bone resorption was tested in an in vivo model. Periapical bone resorption was induced in Sprague-Dawley rats by surgical pulp exposure and subsequent infection from the oral environment. Animals were administered PGG glucan (0.5 mg/kg) or saline (control) subcutaneously the day before and on days 2, 4, 6, 9, 11, 13, 16, and 18 following the pulp exposure procedure. PGG glucan enhanced the number of circulating neutrophils and monocytes and increased neutrophil phagocytic activity approximately two-fold. PGG glucan-treated animals had significantly less infection-stimulated periapical bone resorption than control animals, as determined radiographically (-48.0%; p < 0.001) and by histomorphometry (-40.8% and -42.4% for first and second molars, respectively; p < 0.001). PGG glucan-treated animals also had less soft tissue destruction, as indicated by decreased pulpal necrosis. Only 3.3% of the first molar pulps from PGG glucan-treated animals exhibited complete necrosis, as compared with 40.6% of pulps from controls. Finally, PGG glucan had no effect on either PTH- or IL-1-stimulated bone resorption in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)

UR - http://www.scopus.com/inward/record.url?scp=0029179226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029179226&partnerID=8YFLogxK

M3 - Article

VL - 74

SP - 323

EP - 330

JO - Journal of Dental Research

JF - Journal of Dental Research

SN - 0022-0345

IS - 1

ER -